Bettencourt
P RIS
P RIS Bettencourt TUBERCULOSIS IS A WORLDWIDE DISEASE 1 3 OF - - PowerPoint PPT Presentation
P RIS Bettencourt TUBERCULOSIS IS A WORLDWIDE DISEASE 1 3 OF THE WORLD POPULATION HAS LATENT TUBERCULOSIS MILLION 1.3 DEATHS PER YEAR FIGHT TUBERCULOSIS MODERN WEAPONS with target detect infjltrate sabotage gender study INFILTRATE
Bettencourt
P RIS
OF THE WORLD POPULATION HAS LATENT TUBERCULOSIS
MILLION
detect infjltrate target sabotage gender study
with
detect infjltrate target sabotage gender study
IT MOSTLY AFFECTS THE LUNGS ...
LATENT TB FORMS GRANULOMAS IN THE LUNGS WHERE IT CAN SURVIVE EVEN INSIDE MACROPHAGES
TUBERCULOSIS CAN BE
ACTIVE LATENT
Cytoplasm
TDMH LLO
LLO : Listeriolysin O TDMH : Trehalose Dimycolate Hydrolase
Infjltrating macrophages with an E.coli producing TDMH - an E.coli that lyses mycobacterial cell walls
TDMH-expressing E.coli kill mycobacteria in culture 2 4 6 10
5
10
6
10
7
Mycobaterial Survivors Time (Hours)
Mycobacteria alone Mycobacteria +
Mycobacteria +
BIOBRICKED
C O L L A B O R A T I O N
X 1
detect infjltrate target sabotage gender study
TO DIAGNOSE MULTI DRUG RESISTANCE CAN TAKE FROM
> 21 DAYS TO 3 MONTHS <
gRNA
reporter
reporter Cas9
Antibiotic Resistance
LexA
!
SOS response causes
LexA cleavageXgal
Blue!
lacZ pRecA
Lex A
Chromosome
A biosensor that detects the presence of specifjc antibio- tic resistance genes
10
2
10
3
10
4
10
5
10
6
Surviving transformants (CFU/ml) C A S 9 g R N A B
h
KanR- KanR+
Cotransformation of E. coli with Cas9 and gRNA vectors in Kanamycin Sensitive and Resistant Strains BIOBRICKED
X4Parallel assembly of genes of interest TOOLS
BioBrick Backbone Multiple inserts
SP SP S P EX E X EX Complete BioBrick Plasmid
www.sensigem.org
C O L L A B O R A T I O N
iGEM
2013
OPENDATA TOOLS
(6
Nucleic Acid Biosensors (6) Other Biosensors (221)
Underrepresentation of nucleic acid biosensors
detect infjltrate target sabotage gender study
35% OF ADULTS INFECTED WITH TB ARE WOMEN
vt
Our Advisors & Instructors Our Team
vt
Our Team Our Advisors & Instructors
vt
Our Advisors & Instructors Our Team
731
Synthetic Biology Laboratories SB Conferences Teams screened All info available on wiki
OPENDATA
WOMEN ARE UNDER REPRESENTED SYNTHETIC BIOLOGY AND
in
2007 2009 2011
0%
20% 40% 60% 80% 100%
Women Men
The iGEM gender gap has not changed signifjcantly since 2007 Gender Balance of Synthetic Biology Labs
60 40 20 Labs Phd students Post Doc Head of Labs
Percent of iGEMers Year
What did you hope to learn in iGEM
as much as
0% 10% 20% 30% 40% 50% Percent Women Students Supervisors Judges *
Sex ratio in iGEM according to role
1 2 3 4 5 Working on a team Designing a project General lab experience Human practices Programming and Modeling Leading a team Leading a project
Men Women
Interest level (5 = high)
Women are better represented in winning iGEM teams
0% 10% 20% 30% 40% 50%
*
p = 0.035
Percent women Prize - winners All teams
iGEM a leader and an example of an active gender policy that can be measured
Raise the number of women judges Motivate young women to be advisors Encourage gender refmection in SynBio
detect infjltrate target sabotage gender study
MDR PATIENT ARE
SUCCESSFULLY
TREATED
1 3
CmR
Add sRNA
P h a g e
LB+Cm LB
Plate:
s R N AAntibiotic!
M13 Phage Antibiotic resistance M 1 3 P h a g e Shhh!!!A phage system with low fjtness cost producing sRNA which inhibit the synthesis of antibiotic resistance proteins
Killing Chloramphenicol resistant E.Coli population with Chloramphenicol Origin of resistance of the sequential killing
Concentration of Chloramphenicol (ug/mL) % of surving cells Non infected Infected
Non silenced Non infected
50 500 1000
Adaptable silencing tool
Pr promoter Scaffold Originated from MicC T1/TE 24 bp Target-binding sequence
Anti-Cm
E P S X
BIOBRICKED
X3detect infjltrate target sabotage gender study
ONE NEW DRUG APPROVED IN THE LAST 40 YEARS
WT mycoSIR E.coli
CysI 3NADPH3 NADP CysI FdxA SirA FdxA FprA RED OX SirA FprA FdxA High Throughout Screening High Throughout ScreeningCompare Growth Inhibition
FIND NEW DRUG!
NO GrowthA safe and specifjc high throughput drug screening method that targets essential mycobacteria metabolic proteins
Growth curves of E. coli mycoSIR BIOBRICKED
3 6 9 12 0.1 0.2 0.3 0.4
A
Time (hours) Growth (OD)
0.1 0.2 0.3 0.4
B
WT BL21 MycoSIR E.coli MycoSIR uninduced
BL21 cysl
X3Science and technology always have a human face! Focus on the concrete effects and local circumstances Talk to patients, doctors and policy makers
Nicola Bertoldi
detect infjltrate target sabotage
detect infjltrate target sabotage
4 new biobricks New assembly standard Detection of kanamycin resistance gene
detect infjltrate target sabotage
4 new biobricks New assembly standard Detection of kanamycin resistance gene 1 new biobrick E.coli that kills
detect infjltrate target sabotage
4 new biobricks New assembly standard Detection of kanamycin resistance gene 1 new biobrick E.coli that kills
3 new biobricks Successful silenced antibiotic resistance cassettes Modelling
4 new biobricks New assembly standard Detection of kanamycin resistance gene 3 new biobricks Functional metabolic pathway of M. smegmatis in E. coli Modelling 3 new biobricks Successful silenced antibiotic resistance cassettes Modelling 1 new biobrick E.coli that kills
detect infjltrate target sabotage
Centre for Research and Interdisciplinarity (CRI)
Faculty of Medicine Cochin Port-Royal, South wing, 2nd fmoor Paris Descartes University 24, rue du Faubourg Saint Jacques 75014 Paris FRANCE +33 1 44 41 25 22/25 team2013@igem-paris.org
Bettencourt
P RIS
A Lindner J Wintermute M Toulouze Z Marinkovic
Our Advisors & Instructors Our Team
I Aghoghogbe
C Basier
E Atanasković
M Deyell
M Benony
N Koutsoubelis
S Zahra
S Jaramillo R. V Libis
A Bernheim
Y Zegman
A Löchner C Bencherif
detect infjltrate target sabotage gender study
with